Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

One possible target in acute myeloid leukemia is the reductive carboxylation of glutamine.

2.

Stem Cell Transplant Associated With Better PFS in NKTCL

3.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

4.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

5.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot